Biomarker discovery offers a novel therapeutic approach for rheumatoid arthritis
Rheumatoid arthritis (RA) is the most common form of chronic inflammatory arthritis, characterized by synovitis and progressive destruction of bone and cartilage in the affected joints. Conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) are typically prescribed […]